GDNF and Parkinson disease: Furthermore, a recent clinical trial in which GDNF was infused into the putamen of PD patients via a skull-mounted transcutaneous port and four separate intraputamental infusion catheters also failed to meet its primary endpoint, as GDNF treatment did not lead to significant improvement of the motor symptoms in comparison to placebo control [45].